FDA removes boxed warnings on hormone treatments for menopausal symptoms, suggesting a significant shift in regulation.
The Food and Drug Administration has removed the boxed warnings from the labeling for all hormones used in treating menopausal symptoms. The removal of these warnings has been controversial. Understanding the background leading to these changes can assist nurses in counseling women.
No takes yet. Share an insight, caveat, or question.
Diane S. Aschenbrenner (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: